Mirion Technologies MIR Cancer care — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mirion Technologies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirion Technologies's cancer care — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirion Technologies's cancer care — total revenues?
- Mirion Technologies (MIR) reported cancer care — total revenues of $55.3M in Q1 2026.
- How has Mirion Technologies's cancer care — total revenues changed year-over-year?
- Mirion Technologies's cancer care — total revenues increased by 8.4% year-over-year, from $51M to $55.3M.
- What is the long-term trend for Mirion Technologies's cancer care — total revenues?
- Over 3 years (2022 to 2025), Mirion Technologies's cancer care — total revenues has grown at a 5.1% compound annual growth rate (CAGR), from $206M to $239.1M.
- What does cancer care — total revenues mean?
- This metric represents the total gross revenue generated by the company's cancer care segment, which focuses on radiation oncology quality assurance and patient safety solutions. It reflects the market demand for specialized medical technologies used in cancer treatment and diagnostic workflows. Growth in this figure indicates successful commercial adoption of clinical solutions and expansion within the oncology healthcare market.